Cilnidipine IP 20 mg Tablets are an advanced antihypertensive formulation designed for effective long-term blood pressure management. As a fourth-generation calcium channel blocker (CCB), Cilnidipine blocks both L-type and N-type calcium channels—offering smoother blood pressure control with improved tolerability compared to older CCBs. Cindalin 20 helps relax blood vessels, reduce cardiac workload, and prevent complications linked to hypertension. Its unique dual-channel blocking ability provides added organ protection, helps reduce proteinuria, and minimizes common side effects such as pedal edema and palpitations.
Cilnidipine (20 mg): A dual-action calcium channel blocker that lowers blood pressure by reducing vascular resistance and suppressing sympathetic nerve activity for improved cardiovascular stability.
Superior Hypertension Control: Delivers stable and effective BP reduction with minimal cardiovascular strain.
Dual Mechanism of Action: Blocks both L-type and N-type calcium channels, ensuring better vascular relaxation and reduced sympathetic activity.
Organ Protection: Helps prevent progression of proteinuria and supports kidney and heart health.
Better Tolerability Profile: Lower risk of pedal edema and palpitations compared to traditional calcium channel blockers.
Take as directed by the physician. Swallow the tablet with water. Do not alter dosage without medical guidance. Regular BP monitoring is advised.
May include dizziness, headache, flushing, or mild swelling. Consult a healthcare professional if symptoms persist.
Globus Labs brings you WHO-GMP–certified, high-quality Cilnidipine IP sourced from reputed pharmaceutical manufacturers. Cindalin 20 is formulated to deliver safe, potent, and clinically trusted support.
Whether you’re seeking a franchise opportunity, exploring wholesale distribution, or evaluating Globus Labs for international trade, we’re here to help you build a strong, profitable partnership. Let’s discuss how we can grow together and create meaningful value for your business.